2,044
Views
9
CrossRef citations to date
0
Altmetric
Research Paper

CRTAC1 (Cartilage acidic protein 1) inhibits cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) process in bladder cancer by downregulating Yin Yang 1 (YY1) to inactivate the TGF-β pathway

, , , & ORCID Icon
Pages 9377-9389 | Received 14 Jun 2021, Accepted 25 Aug 2021, Published online: 24 Nov 2021

References

  • Babjuk M, Böhle A, Burger M, et al. EAU guidelines on non-muscle-invasive Urothelial Carcinoma of the Bladder: update 2016. Eur Urol. 2017 Mar;71(3):447–461.
  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424.
  • Güney İB, Küçüker KA, İzol V, et al. The role and effect of FDG-PET/CT on patient management and restaging of bladder carcinoma. Turk J Urol. 2019 Nov;45(6):423–430.
  • Mori K, Mostafaei H, Abufaraj M, et al. Smoking and bladder cancer: review of the recent literature. Curr Opin Urol. 2020 Sep;30(5):720–725.
  • Turati F, Bosetti C, Polesel J, et al. Family history of cancer and the risk of bladder cancer: a case-control study from Italy. Cancer Epidemiol. 2017 Jun;48:29–35.
  • Sanli O, Dobruch J, Knowles MA, et al. Bladder cancer. Nat Rev Dis Primers. 2017 Apr;13(3):17022.
  • Ho CH, Sung KC, Lim SW, et al. Chronic indwelling urinary catheter increase the risk of bladder cancer, even in patients without spinal cord injury. Medicine (Baltimore). 2015 Oct;94(43):e1736.
  • Rava M, Czachorowski MJ, Silverman D, et al. Asthma status is associated with decreased risk of aggressive urothelial bladder cancer. Int J Cancer. 2018 Feb 1;142(3):470–476.
  • Letsiou S, Félix RC, Cardoso JCR, et al. Cartilage acidic protein 1 promotes increased cell viability, cell proliferation and energy metabolism in primary human dermal fibroblasts. Biochimie. 2020 Apr-May;171-172:72–78.
  • Sun Y, Rong X, Li D, et al. Down-regulation of CRTAC1 attenuates UVB-induced pyroptosis in HLECs through inhibiting ROS production. Biochem Biophys Res Commun. 2020 Oct 29;532(1):159–165.
  • Xiao K, Liu Q, Peng G, et al. Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade glioma. PeerJ. 2020;8:e8312.
  • Khachigian LM. The Yin and Yang of YY1 in tumor growth and suppression. Int J Cancer. 2018 Aug 1;143(3):460–465.
  • Lee MH, Lahusen T, Wang RH, et al. Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation. Oncogene. 2012 Jan 5;31(1):116–127.
  • Qu SY, Sun YY, Li YH, et al. YY1 directly suppresses MYCT1 leading to laryngeal tumorigenesis and progress. Cancer Med. 2017 Jun;6(6):1389–1398.
  • Chen Q, Zhang JJ, Ge WL, et al. YY1 inhibits the migration and invasion of pancreatic ductal adenocarcinoma by downregulating the FER/STAT3/MMP2 signaling pathway. Cancer Lett. 2019 Oct 28;463:37–49.
  • Xia W, Li Y, Wu Z, et al. Transcription factor YY1 mediates epithelial-mesenchymal transition through the TGFβ signaling pathway in bladder cancer. Med Oncol. 2020 Sep 24;37(10):93.
  • Dalby B, Cates S, Harris A, et al. Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications. Methods. 2004 Jun;33(2):95–103.
  • Zhao W, Geng D, Li S, et al. LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer. Cancer Med. 2018 Mar;7(3):842–855.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001 Dec;25(4):402–408.
  • Zhang N, Liu JF. MicroRNA (MiR)-301a-3p regulates the proliferation of esophageal squamous cells via targeting PTEN. Bioengineered. 2020 Dec;11(1):972–983.
  • Wang S, Li P, Jiang G, et al. Long non-coding RNA LOC285194 inhibits proliferation and migration but promoted apoptosis in vascular smooth muscle cells via targeting miR-211/PUMA and TGF-β1/S100A4 signal. Bioengineered. 2020 Dec;11(1):718–728.
  • Yuan JB, Gu L, Chen L, et al. Annexin A8 regulated by lncRNA-TUG1/miR-140-3p axis promotes bladder cancer progression and metastasis. Mol Ther Oncolytics. 2021 Sep 24;22:36–51.
  • Xiong Y, Zu X, Wang L, et al. The VIM-AS1/miR-655/ZEB1 axis modulates bladder cancer cell metastasis by regulating epithelial-mesenchymal transition. Cancer Cell Int. 2021 Apr 26;21(1):233.
  • Cao C, Gao R, Zhang M, et al. Role of LKB1-CRTC1 on glycosylated COX-2 and response to COX-2 inhibition in lung cancer. J Natl Cancer Inst. 2015 Jan;107(1):358.
  • Zhang Z, Hu X, Kuang J, et al. LncRNA DRAIC inhibits proliferation and metastasis of gastric cancer cells through interfering with NFRKB deubiquitination mediated by UCHL5. Cell Mol Biol Lett. 2020;25:29.
  • Hua Q, Mi B, Xu F, et al. Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis. Theranostics. 2020;10(11):4762–4778.
  • Seligson D, Horvath S, Huerta-Yepez S, et al. Expression of transcription factor Yin Yang 1 in prostate cancer. Int J Oncol. 2005 Jul;27(1):131–141.
  • Berchuck A, Iversen ES, Lancaster JM, et al. Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Clin Cancer Res off J Am Assoc Cancer Res. 2005 May 15;11(10):3686–3696.
  • Allouche A, Nolens G, Tancredi A, et al. The combined immunodetection of AP-2alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors. BCR. 2008;10(1):R9.
  • de Nigris F, Botti C, de Chiara A, et al. Expression of transcription factor Yin Yang 1 in human osteosarcomas. Eur J Cancer. 2006 Oct;42(15):2420–2424.
  • Zhao G, Li Q, Wang A, et al. YY1 regulates melanoma tumorigenesis through a miR-9 ~ RYBP axis. J Exp Clin Cancer Res. 2015 Jun 24;34(1):66.
  • Soleimani A, Pashirzad M, Avan A, et al. Role of the transforming growth factor-β signaling pathway in the pathogenesis of colorectal cancer. J Cell Biochem. 2019 Jun;120(6):8899–8907.
  • Massagué J. TGF-beta signal transduction. Annu Rev Biochem. 1998;67:753–791.
  • Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet. 2001 Oct;29(2):117–129.
  • Wan A, Miao Y, Peng L, et al. Binding and biologic characterization of recombinant human serum albumin-eTGFBR2 fusion protein expressed in CHO cells. Bioengineered. 2017 Sep 3;8(5):600–612.
  • Yang J, Zhang Y, Song H. A disparate role of RP11-424C20.2/UHRF1 axis through control of tumor immune escape in liver hepatocellular carcinoma and thymoma. Aging (Albany NY). 2019 Aug 23;11(16):6422–6439.
  • Shi H, Xie J, Wang K, et al. LINC01451 drives epithelial-mesenchymal transition and progression in bladder cancer cells via LIN28/TGF-β/Smad pathway. Cell Signal. 2021 May;81:109932.
  • Gao S, Yin H, Tong H, et al. Nucleolar and spindle associated protein 1 (NUSAP1) promotes bladder cancer progression through the TGF-β signaling pathway. Onco Targets Ther. 2020;13:813–825.
  • Yang HJ, Liu GL, Liu B, et al. GP73 promotes invasion and metastasis of bladder cancer by regulating the epithelial-mesenchymal transition through the TGF-β1/Smad2 signalling pathway. J Cell Mol Med. 2018 Mar;22(3):1650–1665.